A Study of ONC201 for Refractory Meningioma

NCT06012929 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Protocol not moving forward.

Conditions

Meningioma
Refractory Meningioma
Relapsed Meningioma

Interventions

DRUG: ONC201

Sponsor

University of Nebraska

Collaborators

[object Object]